ABCELY
Oral immunoglobulin therapy development
- B2B
About ABCELY
Research and development of oral class A immunoglobulin molecules to treat mucosal cancers, endometriosis, and inflammatory bowel diseases through innovative immunotherapy technology.
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- Nantes, Pays de la Loire, France
- Founded
- 2022
- Revenue
- $3.4M – $26.9MTamtam estimate
- Website
- abcely.com
- linkedin.com/company/abcely
ABCELY at a glance
ABCELY is a B2B company in the Biotechnology Research industry, headquartered in Nantes, Pays de la Loire, France.
ABCELY was founded in 2022.
ABCELY has 1–10 employees.
ABCELY's revenue is $3.4M – $26.9M (Tamtam estimate).
Selling to companies like ABCELY?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies